Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-641


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 340, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
PACSIN2 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr22:42869941-42869968 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CACNA1I hsa-miR-641 low: 0 high: 1 1 1 1 0.646
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr22:39634625-39634643 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZBED4 hsa-miR-641 low: 0 high: 1 1 1 1 0.865
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr22:49888212-49888236 HITS-CLIP POSITIVE DIRECT TarBase 7.0
STK4 hsa-miR-641 low: 0 high: 1 1 1 1 0.617
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:45079544-45079565 PAR-CLIP POSITIVE DIRECT TarBase 7.0
GID8 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr20:62947431-62947452 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TM9SF4 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr20:32167205-32167218 HITS-CLIP POSITIVE DIRECT TarBase 7.0
USP14 hsa-miR-641 low: 0 high: 1 1 1 1 0.576
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr18:212052-212074 HITS-CLIP POSITIVE DIRECT TarBase 7.0
METTL4 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr18:2547460-2547481 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RIOK3 hsa-miR-641 low: 0 high: 1 1 1 1 0.813
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr18:23481677-23481694 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PGRMC1 hsa-miR-641 low: 0 high: 1 1 1 1 0.611
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:119244235-119244254 HITS-CLIP POSITIVE DIRECT TarBase 7.0
XIAP hsa-miR-641 low: 0 high: 1 1 1 1 0.788
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chrX:123910117-123910144 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATP11C hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:139728370-139728389 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PLP2 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chrX:49174813-49174840 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDK16 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chrX:47228993-47229014 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZDHHC15 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chrX:75368499-75368523 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NDFIP2 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr13:79553476-79553498 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NFAT5 hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr16:69698495-69698519 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBE2I hsa-miR-641 low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:1312218-1312232 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDK6 hsa-miR-641 low: 0 high: 1 1 1 1 0.845
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:92613700-92613721 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HOXA5 hsa-miR-641 low: 0 high: 1 1 1 1 0.536
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr7:27141616-27141640 HITS-CLIP POSITIVE DIRECT TarBase 7.0